Report - EVAS - Building the clinical evidence · EVAS Zenith IDE Endurant IDE Aorfix IDE Excluder IDE Incraft CE Ovation IDE Type IA, IB Type II Type III/IV Undetermined 0.7% 7.4% 9.8% 17%

Please pass captcha verification before submit form